Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chen Huang has a total of 208 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Single-Cell Pan-Cancer Platelet Atlas Reveals MHC-I Reprogramming and Prognosis

    by Jianxiang Huang, Zihan Wang, Zhiran Zhai, Wanrong Zong, Longbo Bai, Xingyu Chen, Zheng Wu, Jiayue Qiu, Er Li, Jianan Li, et al.

    Platelets provide minimally invasive readouts of cancer biology, yet tumor-induced systemic platelet states remain poorly resolved. Here, we integrated 88 single-cell RNA-sequencing datasets across 24 cancer types and 14 non-cancer diseases to construct a pan-cancer atlas of the hematopoietic stem cell–megakaryocyte–platelet continuum. Among ~60,000 platelets, tumor-enriched subsets displayed a distinct MHC class I-high activation program, enhanced coagulation signatures, and lineage links to reprogrammed megakaryocyte precursors. This program was converted into an MHC class I gene expression index (MGEI) that detected pathological reprogramming across 10 cohorts, validated in an orthotopic lung cancer mouse model. We further derived a core marker-based platelet activation status (PAS) that stratified survival across cohorts and linked platelet activity with multi-omics and H&E histopathological architecture in TCGA-NSCLC. Together, these complementary thromboimmune biomarkers provide a translational framework for platelet-informed risk stratification and precision oncology.

  • Systemic characterization of aging-related phenotypes induced by wild-type and G2019S LRRK2 in Caenorhabditis elegans

    by Chun Li, Fu-Yi Shi, Xuan-Xuan He, Shi-Ying Xiong, Long Gu, Gui-Sheng Wu, Pan-Pan Hou, Chen Huang, Huai-Rong Luo

  • Open Access

    An explainable machine learning model for prognosis prediction in sudden sensorineural hearing loss under integrated therapy

    by Xiaoxiao Ye, Yuxin Deng, Binbin Xiong, Min Chen, Gang Chen, Chen Huang

    Background: Sudden sensorineural hearing loss (SSNHL) is a common otologic emergency with variable prognosis. Reliable prognostic tools, particularly for patients undergoing integrated therapy, remain scarce. Methods: This retrospective study enrolled 227 patients with unilateral SSNHL of the Qi stagnation and blood stasis syndrome who received standardized integrated therapy. Patients were partitioned into training (70%) and validation (30%) sets via outcome-based stratified sampling. To prevent information leakage, all preprocessing and feature selection were conducted strictly within the training set. Eight machine learning models were optimized through five-fold cross-validation (primary metric: AUC). Model performance was systematically evaluated across discrimination, calibration, and clinical utility, with SHapley Additive ExPlanations (SHAP) analysis applied to quantify interpretability and identify key prognostic predictors. Results: The XGBoost model demonstrated superior performance in the validation set (AUC: 0.718; 95% CI: 0.590–0.846), with robust calibration and positive clinical net benefit. SHAP analysis identified four key predictors: activated partial thromboplastin time (APTT), disease duration, platelet count (PLT), and total protein (TP). Non-linear interpretability revealed distinct prognostic thresholds: a critical intervention window was identified within 10 days of symptom onset; optimal recovery was associated with PLT counts of 200–250 × 10 9 /L (risk increased >300 × 10 9 /L) and APTT values of 25–30 s (<25 s indicated higher failure risk). Furthermore, TP exhibited a tri-phasic association, with peak prognostic probability at 65–75 g/L, whereas hypoproteinemia (75 g/L) correlated with reduced recovery likelihood. Conclusion: This study developed an explainable XGBoost-based model, providing an initial framework for prognostic prediction in SSNHL patients. It demonstrates the integration of machine learning with TCM-informed therapy, suggesting potential pathways for personalized care. While promising, the results should be interpreted with caution due to the lack of external validation. Further multicenter prospective studies are crucial to confirm the model’s generalizability and validate the identified biological predictors.


  • Open Access

    MMP3C v2: a network-based framework decoding metabolic plasticity in rheumatoid arthritis, enabling accurate diagnosis and uncovering cell-type-specific metabolic rewiring

    by Xingyu Chen, Zihan Wang, Min Deng, Jianxiang Huang, Naishu Zhang, Zheng Wu, Zelin Yi, Sangyu Li, Jiayue Qiu, Kit-Leong Cheong, et al.

    Metabolic plasticity, the ability of cells to dynamically adapt their metabolic pathways in response to changing environments, is a hallmark of rheumatoid arthritis (RA) pathogenesis and plays a critical role in immune dysfunction. However, scalable methods to quantify inter-pathway crosstalk in RA remain lacking. To address this gap, we present MMP3C v2, an updated network-based framework that integrates gene expression with protein–protein interaction network topology to compute directed pairwise metabolic plasticity (PMP) scores. We applied MMP3C v2 to ~3400 bulk transcriptomes (RA, osteoarthritis, systemic lupus erythematosus, and healthy controls) and ~228 000 single-cell transcriptomics from blood and synovium to profile RA-associated PMP alterations and develop diagnostic classifiers. We found that a single PMP-derived signature demonstrated strong predictive capability for diagnosis. Then, we developed a feature selection pipeline and combined it with 110 machine learning model combinations, by which we established the optimal ensemble classifier (stepwise forward selection + ridge regression), achieving robust and generalized performance (mean area under the curve (AUC) = 0.935; mean F1 score = 0.915) across 12 independent validation cohorts, outperforming seven previously published models. Single-cell analysis revealed cell-type-specific PMP remodeling: a Warburg-like shift in synovial macrophages (↑glycolysis, ↑pentose phosphate pathway, ↓oxidative phosphorylation). Cell–cell communication analysis highlighted FN1-centered signaling linked to glucose metabolic remodeling in myofibroblasts. Collectively, MMP3C v2 establishes metabolic pathway crosstalk as a core diagnostic feature of RA, enabling interpretable and cross-platform diagnostic modeling and the identification of cell-type-specific PMP patterns. The open-source R package mmp3c supports reproducible analysis and broad application.

  • Open Access

    Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8 + T Cell Anti-Tumor Immunity

    by Zhiran Zhai, Jumin Huang, Jiayue Qiu, Yuwei Wang, Jin Liao, Chun Xie, Jiahui Xu, Zebo Jiang, Yajia Xie, Wenkang Ren, et al.

    Lung cancer has the highest mortality rate globally, yet the effective treatment options remain limited. Although short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate are known to modulate immune response and improve the efficacy of cancer therapy, the role of valerate in non-small cell lung cancer (NSCLC) remains unexplored. This study identifies valerate as a biased ligand for GABAB receptor, which specifically binds the GABBR1 subunit, upregulates its expression, and thereby mediates CD8+ T cell anti-tumor immunity in NSCLC. It is demonstrated that GABBR1 overexpression in lung cancer cells suppresses tumor growth both in vitro and in vivo. Single-cell RNA sequencing analysis of public datasets indicates that GABBR1 expression is associated with CXCL13. Mechanically, in vitro and in vivo experiments validate that valerate-induced upregulation of GABBR1 stimulates the secretion of CXCL13, which in turn promotes robust infiltration and activation of CD8+ T cells within the tumor microenvironment. Furthermore, enrichment analysis pinpoints that CXCL13 secretion is negatively transcriptionally regulated by NRF2 and its co-factor ATF4. Analysis of patient samples further confirms that high GABBR1 expression correlates with a longer patient survival rate, underscoring its prognostic value. Overall, these findings identify valerate as a novel immunomodulatory metabolite and propose targeting GABBR1 as a promising strategy to potentiate cancer immunotherapy in lung cancer.


  • Open Access

    Systematic profiling of human gut bacteria with cyclic di-AMP secretion to enhance anti-tumor immunity

    by Linggang Zheng, Jumin Huang, Haoran Ni, Xiaoxian Kuang, Jin Liao, Zepeng Qu, Hongbin Liu, Chen Huang, Lili Yu, Lei Dai, et al.


  • M‐STGCN: A Position‐Aware Multimodal Graph Convolutional Framework for Joint Spatial Domain Identification and Gene Expression Denoising

    by Xin Chen, Chaowen Li, Qirui Zhou, Ning Cui, Yuzhen Huang, Chao Chen, Junyi Lan, Songqing Gu, Hongtao Liu, Chao Yang, et al.

    Spatially transcriptomics (ST) has revolutionized our ability to profile gene expression within the architectural complexity of tissue microenvironments. However, decoding spatial heterogeneity requires robust multimodal data integration that unifies gene expression, spatial positions, and histopathological images to overcome modality‐specific biases. Here, we propose M‐STGCN, a multimodal unsupervised framework that constructs a spatial weight matrix from spatial coordinates to simultaneously refine both gene expression profiles and image features, by which we establish position‐aware feature enhancement served as a core innovation before graph fusion. Verified on human brain and breast cancer datasets, M‐STGCN significantly improves the accuracy of spatial domain identification. Ablation studies confirm the importance of its position‐aware and image modality integration. For ST platforms lacking images and at diverse resolutions, M‐STGCN maintains robust performance utilizing only gene expression and spatial coordinates. By effectively denoising raw spatial transcriptomic profiles, our approach identifies more significant spatial domain marker genes, as well as potential prognostic biomarkers for breast cancer. Moreover, M‐STGCN reveals that image features and spatial information contribute equally to breast cancer analysis, underscoring the critical role of image features. As a versatile and scalable tool, M‐STGCN enables unbiased integration of multimodal data, facilitating the deciphering of spatial heterogeneous in complex tissues.


  • Open Access

    Supplementary Table S13 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

    by Dongliang Leng, Ziyi Yang, Heng Sun, Chengcheng Song, Chen Huang, Ka U. Ip, Guokai Chen, Chu-Xia Deng, Xiaohua Douglas Zhang, Qi Zhao

    Supplementary Table S13. Univariate and multivariable Cox regression analysis of nodes involved in the prognostics related ceRNA network.

  • Open Access

    Supplementary Table S6 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

    by Dongliang Leng, Ziyi Yang, Heng Sun, Chengcheng Song, Chen Huang, Ka U. Ip, Guokai Chen, Chu-Xia Deng, Xiaohua Douglas Zhang, Qi Zhao

    Supplementary Table S6. GO analysis for DE genes between C1(Low) and High(C2).

  • Open Access

    Supplementary Figure S2 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

    by Dongliang Leng, Ziyi Yang, Heng Sun, Chengcheng Song, Chen Huang, Ka U. Ip, Guokai Chen, Chu-Xia Deng, Xiaohua Douglas Zhang, Qi Zhao

    Supplementary Figure S2. Validation of subtypes of SARC using Consensus clustering analysis.